University of California San Francisco
Displaying 31 - 60 of 16893
-
-
Global Rules Could Cut Costs and Speed Access to GLP-1 Drugs
UCSF research shows that international rules for biosimilars, mimics of biologic drugs like Ozempic and insulin, need to improve and match each another to encourage biosimilar development, testing, and approval. This would dramatically improve drug affordability just like generics has done.
-
Do Red Light Therapy Masks Actually Work? Here’s What Dermatologists Say
-
2026 Chancellor Distinguished Service Awards
UCSF salutes the individuals whose exemplary service reflects the university’s sustained commitment to serving our people and the broader community.
-
Can an Alzheimer’s Blood Test Detect Early, Subtle Cognitive Decline?
About 6% of asymptomatic adults have a biomarker for Alzheimer's disease and are already showing very subtle signs of the disease that would not come to light in a standard cognitive test.
-
Innovative Diabetes Researcher Joins National Academy of Sciences
Mark Anderson, MD, PhD, a pioneer in diabetes research and professor of medicine at UCSF, has been elected to the National Academy of Sciences — one of the highest honors in American science.
-
Improving Prediction of Alzheimer’s Disease with AI
A team at UCSF developed a multitask deep learning framework that can effectively predict Alzheimer’s disease diagnosis, cognitive scores, and future cognitive decline using only baseline MRI and demographics.
-
Health Coaches Improve Outcomes for Patients with Asthma and COPD
Pairing vulnerable, low-income patients with asthma coaches can improve outcomes and may also reduce costs associated with avoidable health care use.
-
How to Overcome Global Price Barriers for New Alzheimer’s Drugs
In the last few years, progress has been made in the fight against Alzheimer’s disease with a class of therapies called anti-amyloid antibodies (anti-Aβ). These anti-Aβ therapies, like lecanumab
-
The Liver’s Immune Cells Might Be the Key to Curing Hepatitis B
Jody Baron and Gabi Fragiadakis discover why some people with chronic Hepatitis B are cured after they're taken off of antiviral drugs, despite falling severely ill when the drug regiment stops.
-
Why Measles Is Spreading Again and Who Faces the Highest Risk
UCSF expert Charles Chiu discusses rising measles cases, extreme contagiousness, and why 95% vaccination rates are vital for community safety.
-
This Anti-CRISPR Stops the Protein Assembly Line in Bacteria
Joe Bondy-Denomy solves a CRISPR caper: this is how a viral protein stows itself on protein factories in bacteria, and destroys a CRISPR protein, designed to kill viruses, while it's being made.
-
Are Your Meds and DNA a Bad Match? This Test Alerts Clinicians
UCSF’s pharmacogenetics program uses DNA testing to personalize prescriptions, reducing side effects and ensuring the right drug and dose for every patient.
-
2026 Alumni Awards Recognize Visionary Leaders Shaping the Future of Health
The Alumni Association of UCSF (AAUCSF) announced the recipients of the 2026 UCSF Alumni Achievement Awards, recognizing outstanding alumni from UCSF’s schools.
-
UCSF Receives Major Gift to Advance Research and Modernization
UCSF has received a $100 million commitment from longtime supporters Kathy Chiao and Kenneth Hao to address its most urgent capital needs and accelerate innovation to advance human health.
-
In the Face of Cuts, W.M. Keck Foundation Supports Vital Research
Six pairs of UC San Francisco faculty members and their PhD students have been awarded funding through the W. M. Keck Foundation’s inaugural Scholar-Fellow Bridge Initiative, a program designed to
-
How UCSF Teams with Oakland Mayor, Faith Leaders to Stop Violence
Attendees at a community breakfast for Oakland faith leaders hosted by Nicholas Holmes and Oakland Mayor Lee discussed youth violence prevention initiatives and other community topics.
-
UCSF Community Honors Life of Doris Fisher (1931 – 2026)
Doris Fisher, a visionary philanthropist and longtime champion of UCSF who passed away in May 2026, devoted more than four decades to advancing the university’s mission. She served as a Lifetime Director on the UCSF Foundation Board and played a key role in building the UCSF Foundation.
-
UC Regents Approve New UCSF Bakar Ear & Hearing Institute
The University of California Board of Regents approved plans for the UCSF Bakar Ear & Hearing Institute, a new, state-of-the-art ear facility at UCSF’s Mission Bay campus, taking the first step to creating one of the world’s leading centers for advancing research and care for hearing and balance disorders.
-
Can Blockbuster GLP-1 Weight-Loss Drugs Also Protect Brain Health?
Multiple clinical trials have shown that GLP-1s are safe and effective for patients with obesity, diabetes and cardiovascular conditions. New evidence shows that the drugs may also protect against neurological diseases, like dementia, Parkinson's, and substance use disorder.
-
One Dose of Psilocybin Changes the Human Brain
A large team of scientists, found that a single dose of psilocybin created positive changes in the brain and well-being, one hour and one month after administration.
-
UCSF Health Named to Becker’s Top Workplaces in Health Care List
UCSF Health was named a top place to work by Becker's Healthcare.
-
This Center Aims to Slow Colon Cancer Epidemic in Young Adults
UCSF Health is launching a special clinic for young adults with colorectal cancer, of which one in five cases now affects younger people, and is a leading cause of cancer death in people aged twenty to forty.
-
Love Family Gives $2.5M to Advance Sickle Cell Care at UCSF
A $2.5 million gift by Ted W. Love and Joyce Y. Love to UCSF Benioff Children’s Hospitals will expand care for patients with sickle cell disease and support the building of new facilities at the campus.
-
No Brain Required: This Is How the Single-Celled “Stentor” Learns
A team of researchers discover how the <i>stentor</i>, an organism made of a single, gigantic cell, learns without a brain.
-
HD Probes Show for the First Time How Epileptic ‘Brain Blips’ Occur
Epilepsy physicians Jon Kleen and Eddie Chang used high-resolution technology to see how cognition is disrupted in people with epilepsy and predict when it will occur. The new view points the way to being able to fend of these disruptions.
-
Jennifer Cocohoba Reflects on Time, Connection, and Care in 2026 Last Lecture
A UCSF professor explores the value of time and connection, urging a shift from career checklists to genuine human care in this annual talk.
-
Portable TB Test Matches Lab Accuracy in Just Minutes
A global team of scientists and clinicians found that a cheap, easy-to-use test for tuberculosis was just as good, if not better, at detecting disease than existing tests, shortening time to a diagnosis from days to just 15 minutes.
-
3 UCSF Faculty Honored for Advancing Science and Society
The American Association for the Advancement of Science, one of the world’s largest general scientific societies and publisher of the Science family of journals, named three UCSF faculty to the 2025 class of AAAS Honorary Fellows: Elissa Epel, Geeta Jayant Narlikar, and Donald Emil Ganem (emeritus).
-
How This Antibiotic Helped STI Cases Drop in San Francisco
Discover how SF became the first city to use doxycycline to drop STI rates by up to 24%. UCSF experts explain the impact of doxy-PEP.
